Article
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.
The Journal of experimental medicine - 17 Nov 2014
Klein Florian, Nogueira Lilian, Nishimura Yoshiaki, Phad Ganesh, West Anthony P, Halper-Stromberg Ariel, Horwitz Joshua A, Gazumyan Anna, Liu Cassie, Eisenreich Thomas R, Lehmann Clara, Fätkenheuer Gerd, Williams Constance, Shingai Masashi, Martin Malcolm A, Bjorkman Pamela J, Seaman Michael S, Zolla-Pazner Susan, Karlsson Hedestam Gunilla B, Nussenzweig Michel C
Abstract excerpt
Antibody-mediated immunotherapy is effective in humanized mice when combinations of broadly neutralizing antibodies (bNAbs) are used that target nonoverlapping sites on the human immunodeficiency virus type 1 (HIV-1) envelope. In contrast, single bNAbs can control simian-human immunodeficiency virus (SHIV) infection in immune-competent macaques, suggesting that the host immune response might also contribute to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
